Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Feb;22(1):114-6.
doi: 10.3346/jkms.2007.22.1.114.

The effects of L-thyroxine treatment on QT dispersion in primary hypothyroidism

Kyoung Hee Kweon  1 , Byoung Hyun Park, Chung Gu Cho
Affiliations

The effects of L-thyroxine treatment on QT dispersion in primary hypothyroidism

Kyoung Hee Kweon et al. J Korean Med Sci. 2007 Feb.

Abstract

Hypothyroidism has various cardiovascular manifestation and exhibits electrocardiographic change. The QT dispersion on surface ECG reflects regional variations in myocardial repolarization. The effect of L-thyroxine treatment on ECG parameters, such as QT dispersion, in patients with primary hypothyroidism were investigated. This study involved 18 patients (3 men, 15 women, ages: 48+/-18 yr) with primary hypothyroidism. All patients were checked with a standard 12-lead ECG before and after L-thyroxine treatment. Various ECG parameters were then measured twice. The mean L-thyroxine treatment duration was 22+/-2.7 months. The mean thyroid-stimulating hormone levels of patients before and after therapy were 40.2+/-29.8 microU/mL, 3.6+/-4.6 microU/mL (p<0.001) and free-T4 levels were 0.44+/-0.38 ng/dL, 1.51+/-0.39 ng/dL (p<0.001). After L-thyroxine treatment, QT interval (395+/-42 vs. 380+/-24 msec, p<0.05), QTc interval (434+/-32 vs. 417+/-23 msec, p<0.05), QT dispersion (45+/-23 vs. 30+/-13 msec, p=0.008), QTc dispersion (49+/-23 vs. 32+/-14 msec, p=0.005) significantly decreased. There were no significant changes in the PR and RR intervals, as well as the QRS duration. Our findings suggest that the thyroid hormone affects ventricular inhomogenicity, and that L-thyroxine replacement therapy may reduce malignant ventricular arrhythmia and sudden cardiac death in primary hypothyroidism.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Serial Electrocardiograms. (A) An ECG before L-thyroxine treatment shows QT prolongation (QTc=485 msec) and T-inversion in left precordial leads. (B) An ECG after L-thyroxine treatment shows normal QT interval (QTc=432 msec) and an upright T-wave.
See this image and copyright information in PMC

References

    1. Serma JS, Venkataraman K, Nicod P, Polikar R, Smith J, Schoenbaum MP, Singh BN. Circadian rhythmicity of rate-normalized QT interval in hypothyroidism and its significance for development of class III antiarrhythmic agents. Am J Cardiol. 1990;66:959–963. - PubMed
    1. Nathaniel C, Caleb L, Azrin MA. QTc prolongation in hypothyroidism. J Am Coll Cardiol. 1994;23:36A.
    1. Schenck JB, Rizvi AA, Lin T. Severe primary hypothyroidism manifesting with torsades de pointes. Am J Med Sci. 2006;331:154–156. - PubMed
    1. Hii JT, Wyse DG, Gillis AM, Duff HJ, Solylo MA, Mitchell LB. Precordial QT interval dispersion as a marker of torsade de pointes. Circulation. 1992;86:1376–1382. - PubMed
    1. Yunus A, Gillis AM, Duff HJ, Wyse DG, Mitchell LB. Increased precordial QTc dispersion predicts ventricular fibrillation during acute myocardial infarction. Am J Cardiol. 1996;78:706–708. - PubMed

Publication types